Four-times-a-day dosing frequency is better than a twice-a-day regimen in subjects requiring a high-dose inhaled steroid, budesonide, to control moderate to severe asthma

American Review of Respiratory Disease

Volumn 140, Issue 3 I, 1989, Pages 624-628

  Malo, J L ^a   Cartier, A ^a   Merland, N ^a   Ghezzo, H ^a   Burek, A ^a   Morris, J ^a   Jennings, B H ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE;

ADULT; AGED; ASTHMA; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0024437990     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm/140.3.624     Document Type: Article

References (0)